| Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis M Francone, F Iafrate, GM Masci, S Coco, F Cilia, L Manganaro, ... European radiology 30, 6808-6817, 2020 | 822 | 2020 |
| Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID … MA Zingaropoli, P Nijhawan, A Carraro, P Pasculli, P Zuccala, V Perri, ... Frontiers in immunology 12, 627548, 2021 | 70 | 2021 |
| Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis MR Ciardi, M Iannetta, MA Zingaropoli, R Salpini, M Aragri, R Annecca, ... Open forum infectious diseases 6 (1), ofy356, 2019 | 70 | 2019 |
| Major reduction of NKT cells in patients with severe COVID-19 pneumonia MA Zingaropoli, V Perri, P Pasculli, FC Dezza, P Nijhawan, G Savelloni, ... Clinical Immunology 222, 108630, 2021 | 49 | 2021 |
| B-and T-cell responses after SARS-CoV-2 vaccination in patients with multiple sclerosis receiving disease modifying therapies: immunological patterns and clinical implications M Iannetta, D Landi, G Cola, L Campogiani, V Malagnino, E Teti, ... Frontiers in Immunology 12, 796482, 2022 | 31 | 2022 |
| Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV‐associated atherosclerosis A D’Abramo, MA Zingaropoli, A Oliva, C D’Agostino, S Al Moghazi, ... Mediators of inflammation 2014 (1), 192594, 2014 | 31 | 2014 |
| Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation M Iannetta, MA Zingaropoli, A Bellizzi, M Morreale, S Pontecorvo, ... PloS one 11 (8), e0160277, 2016 | 29 | 2016 |
| The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia MR Ciardi, MA Zingaropoli, P Pasculli, V Perri, M Tartaglia, S Valeri, ... Journal of neuroimmunology 346, 577323, 2020 | 27 | 2020 |
| JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis MR Ciardi, MA Zingaropoli, M Iannetta, C Prezioso, V Perri, P Pasculli, ... Virology journal 17, 1-8, 2020 | 22 | 2020 |
| Neuro-axonal damage and alteration of blood–brain barrier integrity in COVID-19 patients MA Zingaropoli, M Iannetta, L Piermatteo, P Pasculli, T Latronico, ... Cells 11 (16), 2480, 2022 | 17 | 2022 |
| Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? C Prezioso, MA Zingaropoli, M Iannetta, DM Rodio, M Altieri, A Conte, ... Multiple Sclerosis and Related Disorders 41, 102008, 2020 | 17 | 2020 |
| Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients A D’Abramo, MA Zingaropoli, A Oliva, C D’Agostino, S Al Moghazi, ... PLoS One 11 (2), e0149601, 2016 | 17 | 2016 |
| Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium … G Bruno, A Gagliardi, A Oliva, M Trancassini, A Macone, C Cicerone, ... New Microbiol 42 (4), 221-4, 2019 | 16 | 2019 |
| Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment V Pietropaolo, A Bellizzi, E Anzivino, M Iannetta, MA Zingaropoli, ... Journal of Neurovirology 21, 653-665, 2015 | 16 | 2015 |
| Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients M Iannetta, MA Zingaropoli, T Latronico, I Pati, S Pontecorvo, C Prezioso, ... Scientific reports 9 (1), 311, 2019 | 15 | 2019 |
| COVID-19 affects serum brain-derived neurotrophic factor and neurofilament light chain in aged men: implications for morbidity and mortality C Petrella, MA Zingaropoli, FM Ceci, P Pasculli, T Latronico, GM Liuzzi, ... Cells 12 (4), 655, 2023 | 14 | 2023 |
| PaO2/FiO2 ratio forecasts COVID-19 patients’ outcome regardless of age: a cross-sectional, monocentric study G Sinatti, SJ Santini, G Tarantino, G Picchi, B Cosimini, F Ranfone, ... Internal and Emergency Medicine, 1-9, 2022 | 14 | 2022 |
| Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality P Pasculli, MA Zingaropoli, GM Masci, L Mazzuti, V Perri, F Paribeni, ... New Microbiol 44 (3), 145-54, 2021 | 13 | 2021 |
| JC Virus‐DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC … MA Zingaropoli, M Iannetta, S Pontecorvo, E Anzivino, C Prezioso, ... BioMed research international 2018 (1), 5297980, 2018 | 11 | 2018 |
| Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine F Dominelli, MA Zingaropoli, M Tartaglia, E Tortellini, M Guardiani, V Perri, ... Frontiers in Immunology 13, 1050183, 2022 | 9 | 2022 |
